Drug results: 2
| fluvoxamine | A selective serotonin reuptake inhibitor that is used in the treatment of DEPRESSION and a variety of ANXIETY DISORDERS. Because of its high affinity at the sigma-1 receptor, the drug was evaluated whether could prevent clinical deterioration in patients with COVID-19. At the moment, there are insufficient data to recommend either for or against use of fluvoxamine for the treatment of COVID-19. |
|
| pirfenidone | pyridone, indicated for the treatment of idiopathic pulmonary fibrosis |
|








Citing DrugCentral © 2025.
License